Show
Sort by
-
Three-year survival result of CORE (Capecitabine, Oxaliplatin, Radiotherapy and Excision) study after post-operative chemotherapy in patients with locally advanced rectal adenocarcinoma
(2009) -
Association of Progression-free Survival, Overall Survival, and Patient-reported Outcomes by Skin Toxicity and KRAS Status in Patients Receiving Panitumumab Monotherapy
-
DOUBLE BLIND RANDOMIZED PHASE II STUDY WITH RADIATION+5-FLUOROURACIL +/- CELECOXIB FOR RESECTABLE RECTAL CANCER
-
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study
-
Quality assurance and recommendations for quality assessment of screening colonoscopy in Belgium.
-
Diagnostic pitfalls in digestive neuroendocrine tumours
-
Role of chemotherapy in gastro-entero-pancreatic neuroendocrine tumors: the end of a story?
-
The antiproliferative effect of somatostatin analogs: clinical relevance in patients with neuroendocrine gastro-entero-pancreatic tumours.
-
The potential role of targeted therapies in the management of neuroendocrine tumours
-
Locoregional and radioisotopic targeted treatment of neuroendocrine tumours